10 June 2026
The lenacapavir HIV Prevention Injection rollout begins in SA, but activists warn that limited supply from Gilead could blunt the impact.
2 June 2026
The Semaglutide Compounding Dispute intensifies as Novo Nordisk takes iDexis to court over illegal manufacturing of weight-loss injections.
1 June 2026
Compounded GLP-1 injections are at the centre of a regulatory dispute. iDexis challenges SAHPRA and SAPC recall orders.
1 June 2026
Learn how SAHPRA is addressing illicit GLP-1 manufacturing following recent raids on compounding pharmacies in Pretoria.
27 May 2026
SAHPRA and SAPC launch an unregistered GLP-1 medicines crackdown, seizing GLP-1 products at a Pretoria pharmacy.
25 May 2026
Substandard And Falsified Medicines threaten South Africa as SAHPRA warns informal sales can cause treatment failure, harm and death.
8 May 2026
Aspen Insulin approval marks a milestone for diabetes care in South Africa, ensuring supply security with locally made insulin.
10 February 2026
Bogus doctors remain a serious risk, says the HPCSA, as arrests rise and patients are urged to verify practitioners on the online register.
7 February 2026
14 January 2026
GLP-1 weight loss drugs like Mounjaro and Wegovy are transforming obesity treatment in SA amid rising health concerns and systemic barriers.
9 January 2026
HIV prevention in South Africa hinges on local drug manufacturing to ensure access, reduce delays, and enable regional health security.
5 November 2025
Lenacapavir has been registered by SAHPRA as an innovative HIV prevention injection. Find out more about its rollout in South Africa.